CHARACTERIZATION OF THE ABILITY OF TUMOR CELLS OF VARIOUS MORPHOLOGICAL STRUCTURES TO MODULATE IMMUNE-INFLAMMATORY REACTIONS IN INVASIVE BREAST CARCINOMA
PDF (Русский)

Keywords

MORPHOLOGICAL HETEROGENEITY
IMMUNO-INFLAMMATORY REACTIONS
EXPRESSION PROFILE
MICROENVIRONMENT
BREAST CANCER

How to Cite

Tashireva, L., Gerashchenko, T., Denisov, Y., Saveleva, O., Buzenkova, A., Zavyalova, M., Cherdyntseva, N., & Perelmuter, V. (2020). CHARACTERIZATION OF THE ABILITY OF TUMOR CELLS OF VARIOUS MORPHOLOGICAL STRUCTURES TO MODULATE IMMUNE-INFLAMMATORY REACTIONS IN INVASIVE BREAST CARCINOMA. Voprosy Onkologii, 66(3), 270–276. https://doi.org/10.37469/0507-3758-2020-66-3-270-276

Abstract

The aim of the study was to assess the ability of tumor cells of invasive breast carcinoma of a non-specific type (IC NST) which forming various morphological structures to modulate their nearest microenvironment. Material and methods. An analysis was carried out of the data on the expression of the immune system (cytokines, including chemokines, and their receptors, pattern-recognizing molecules and growth factors) genes placed in the GEO database (Gene Expression Omnibus, number GSE80754). Results. The largest number of overexpressing genes that functionally provide parenchymal-stromal relationships is observed in discrete tumor cells. The spectrum of genes that contributed to the polarization in Th2 type of the immuno-inflammatory response was a characteristic for tumor cells building trabecular structures. Cells of tubular structures are characterized by overexpression of the IL15 gene, which attracts NK cells. Alveolar and solid structures do not have a pronounced ability to modulate their microenvironment. Conclusion. Tumor elements of various morphological structures of IC NST are characterized by functional heterogeneity in their ability to influence the type of immuno-inflam-matory reactions in their microenvironment.

https://doi.org/10.37469/0507-3758-2020-66-3-270-276
PDF (Русский)

References

Злокачественные новообразования в России в 2018 году (заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. - М.: МНИ-ОИ им. П.А. Герцена - филиал ФГБУ "НМИЦ радиологии" Минздрава России. - 2019. - илл. - 250 с.

Masood S. Breast Cancer Subtypes: Morphologic and Biologic Characterization //

Sinn H.P, Kreipe H. A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition // Breast Care (Basel). - 2013. - № 2. - P. 149-154. - DOI: 10.1159/000350774

Hill B.S., Sarnella A., D'Avino G., Zannetti A. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer // Semin Cancer Biol. - 2019. - pii: S 1044-579X(19)30211-1. - DOI: 10.1016/j.semcancer.2019.07.028

Horsman M.R., Vaupel P Pathophysiological Basis for the Formation of the Tumor Microenvironment // Front Oncol. - 2016. - № 6. - P 66. - DOI: 10.3389/fonc.2016.00066

Zboralski D., Hoehlig K., Eulberg D. et al. Increasing tumor infiltrating T cells through inhibition of CXCL12 with NOX-A12 synergizes with PD-1 blockade // Cancer Immunol Res. - 2017. - № 5. - P. 950-956.

Li X., Gruosso T, Zuo D. et al. Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer // Proc Natl Acad Sci USA. -2019. - Vol. 116. - № 9. - P 3678-3687. - DOI: 10.1073/pnas.1817652116

Dongre A., Weinberg R.A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer // Nat Rev Mol Cell Biol. - 2019. - Vol. 20. - № 2. - P. 69-84. - DOI: 10.1038/s41580-018-0080-4

Hsu D.S., Wang H.J., Tai S.K. et al. Acetylation of snail modulates the cytokinome of Cancer Cells to enhance the recruitment of macrophages // Cancer Cell. - 2014. - Vol. 26. - № 4. - P 534-48. - DOI: 10.1016/j.ccell.2014.09.002

Taki M., Abiko K., Baba T. et al. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation // Nat Commun. - 2018. - Vol. 9. - № 1. - P. 1685. - DOI: 10.1038/s41467-018-03966-7

Zavyalova M.V., Denisov E.V., Tashireva L.A. et al. Phenotypic drift as a cause for intratumoral morphological heterogeneity of invasive ductal breast carcinoma not otherwise specified // Biores Open Access. - 2013. - № 2. - P. 148-54. - DOI: 10.1089/biores.2012.0278

Denisov E.V., Skryabin N.A., Gerashchenko T.S. et al. Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44+CD24-stemness // Oncotarget. - 2017. - Vol. 8. - № 37. - P. 61163-61180. - DOI: 10.18632/oncotarget.18022

Allen F., Bobanga I.D., Rauhe P. et al. CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNy // Oncoimmunology. - 2017. - Vol. 7. - № 3. - P e1393598. - DOI: 10.1080/2162402X.2017.1393598

Liu Z.-K., Wang R.-C., Han B.-C. et al. A Novel Role of IGFBP7 in Mouse Uterus: Regulating Uterine Receptivity through Th1/Th2 Lymphocyte Balance and Decidualization // PLoS ONE. - 2012. - Vol. 7. - № 9. - P. e45224. - DOI: 10.1371/journal.pone.0045224

Maeda H., Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice // J Immunol. -1996. - Vol. 156. - № 1. - P. 73-78.

Mandal P.K., Biswas S., Mandal G. et al. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF- -induced breast cancer progression // Immunobiology. - 2018. - Vol. 223. - № 2. - P. 151-161. - DOI: 10.1016/j.imbio.2017.10.031

Tulotta C., Lefley D.V., Freeman K. et al. Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment // Clin Cancer Res [Internet]. - 2019. - doi: clin-canres.2202.2018.

Skobe M., Hawighorst T, Jackson D.G. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis // Nat Med. - 2001. - Vol. 7. - № 2. - P. 192-198.

Qu H., Cui L., Meng X. et al. C1QTNF6 is overexpressed in gastric carcinoma and contributes to the proliferation and migration of gastric carcinoma cells // International Journal of Molecular Medicine. - 2019. - Vol. 43. - № 1. - P. 621-629. -. DOI: 10.3892/ijmm.2018.3978

Alexopoulou L., Holt A.C., Medzhitov R, Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 // Nature: journal. - 2001. - Vol. 413. - № 6857. - P 732-738. -. DOI: 10.1038/35099560

Takahashi M., Miura Y, Hayashi S. et al. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheuma toid synovial fibroblasts // Int J Mol Med. - 2011. - Vol. 28. - № 3. - P 423-427. - DOI: 10.3892/ijmm.2011.687

Hsieh S.L., Lin W.W. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions // J Biomed Sci. - 2017. - Vol. 24. - № 1. - P. 39. - DOI: 10.1186/s12929-017-0347-7

Lee C.C., Lin J.C., Hwang W.L. et al. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization // Nat Commun. - 2018. - Vol. 9. - № 1. - P 3763. - DOI: 10.1038/s41467-018-06268-0

Meijer J., Zeelenberg I.S., Sipos B., Roos E. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver // Cancer Res. - 2006. - Vol. 66. - № 19. - P 9576-9582.

Tominaga K., Shimamura T., Kimura N. et al. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells // Oncogene. - 2017. - Vol. 36. - № 9. - P 1276-1286. - DOI: 10.1038/onc.2016.293

Nold M.F., Nold-Petry C.A., Zepp J.A. et al. IL-37 is a fundamental inhibitor of innate immunity // Nat Immunol. -2010. - Vol. 11. - № 11. - P. 1014-1022. - DOI: 10.1038/ni.1944

Jovanovic B., Beeler J.S., Pickup M.W. et al. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymalstem like triple negative breast cancer // Breast Cancer Res. - 2014. - Vol. 16. - № 4. - P R69. - DOI: 10.1186/bcr3684

Yang J., Min K.W., Kim D.H. et al. High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts // PLoS One. - 2018. - Vol. 13. - № 8. - P. e0202113. - DOI: 10.1371/journal.pone.0202113

Yang C., Lin C., Jiang J. The expression of interleukin 17 receptor A is associated with poor prognosis in patients with colorectal cancer and its knockdown inhibits tumor growth and modulates tumor-infiltrating immune cells in mice tumor // Annals of Oncology. - 2017. - Vol. 28. -Sup. 5. - doi: mdx393.106.

Heidemann J., Ogawa H., Dwinell M.B. et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 // J Biol Chem. - 2003. - Vol. 278. - № 10. - P 8508-8515.

Miller R.J., Banisadr G., Bhattacharyya B.J. CXCR4 signaling in the regulation of stem cell migration and development // J Neuroimmunol. - 2008. - Vol. 198. - № 1-2. - P 31-38. - DOI: 10.1016/j.jneuroim.2008.04.008

Qu Y, Liao Z., Wang X., et al. EFLDO sensitizes liver cancer cells to TNFSF10-induced apoptosis in a p53-dependent manner // Mol Med Rep. - 2019. - Vol. 19. - № 5. - P 3799-3806. - DOI: 10.3892/mmr.2019.10046

Gillgrass A.E., Chew M.V., Krneta T, Ashkar A.A. Overexpression of IL-15 promotes tumor destruction via NK1.1 + cells in a spontaneous breast cancer model // BMC Cancer. - 2015. - № 15. - P. 293. - DOI: 10.1186/s12885-015-1264-3

Saintigny P, Massarelli E., Lin S. et al. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma // Cancer Res. - 2013. - Vol. 73. - № 2. - P. 571-582. - DOI: 10.1158/0008-5472.CAN-12-0263

Завьялова М.В. Взаимосвязь морфологического фенотипа опухоли, лимфогенного и гематогенного метастазирования при инфильтрирующем протоковом раке молочной железы: автореф. дис.... д-ра мед. наук. Томск, 2009. - 41 с.

Lustberg M.B., Balasubramanian P., Miller B. et al. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients // Breast Cancer Research. - 2014. - № 16. - P R23

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2020